Experimental treatments of endometriosis. - Wikidata - wikimedia - TriplyDB

Experimental treatments of endometriosis.

Experimental treatments of endometriosis.

http://www.wikidata.org/entity/Q38575273

about

Experimental treatments of endometriosis.

http://www.wikidata.org/entity/Q38575273

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Experimental treatments of endometriosis.

@en

type

label

Experimental treatments of endometriosis.

@en

prefLabel

Experimental treatments of endometriosis.

@en

P1433

Q38575273-EC408965-9AB4-40BA-9221-4C4C03F2FCAE

P1476

Q38575273-76F1CCA9-1564-49FA-AC81-87E25AAABFF8

P2093

Q38575273-6B74A2A7-9E2E-43A5-AD58-0DA90ED38A25

Q38575273-FE7D12D1-0077-4E97-B259-708FFC02EB6D

P2860

Q38575273-01E08703-F4DC-4409-9D45-0826D23DBF3B

Q38575273-05AFEA79-81A4-4DD0-9E9C-75A1C04C115D

Q38575273-05C469D1-9851-4AF8-836B-D39174DC18B3

Q38575273-0BFF2103-C10C-49AB-95CC-988732665D25

Q38575273-0DE12A30-E62A-424F-9EA3-A98ACF3F682C

Q38575273-111F6BEB-EA84-4FE2-8DD7-069FB7B68DB6

Q38575273-120C1E84-E742-4AF3-BDD6-A8EB3E54BB4A

Q38575273-126CC5E7-DA6F-4BF9-AD5D-2271E96D0001

Q38575273-1A241762-28F3-4684-A232-A5419730EA51

Q38575273-1DBFC0BC-3D30-49F1-91F7-848451DBCDE6

P304

Q38575273-FEF0F9C3-1762-4775-9C74-BA4A980B7854

P31

Q38575273-C3DDEF4F-6DCD-4C6A-8704-4159D9F5A1C1

P356

Q38575273-80DF7E5E-6000-4F28-B2EE-7CF958AAB7BD

P433

Q38575273-4FC511CD-DD48-44A6-910F-131FA64A78ED

P478

Q38575273-0D35F290-F0DB-495E-A20A-803C860835F5

P577

Q38575273-E0AE4BE3-153C-4AAE-8306-02C92E1D8D06

P698

Q38575273-093BB22B-9950-429F-A593-BE29E0D3A23E

P921

Q38575273-18583037-A283-4AE0-84D8-27AB3A9BDB0A

P356

P1433

P1476

Experimental treatments of endometriosis.

@en

P2093

Erkut Attar

http://www.w3.org/2001/XMLSchema#string

Rukset Attar

http://www.w3.org/2001/XMLSchema#string

P2860

The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor

The emerging use of aromatase inhibitors for endometriosis treatment

A structural and in vitro characterization of asoprisnil: a selective progesterone receptor modulator

Effect of pentoxifylline on vascular endothelial growth factor C and flk-1 expression on endometrial implants in the rat endometriosis model

High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis

The immunoconjugate "icon" targets aberrantly expressed endothelial tissue factor causing regression of endometriosis

Novel therapies targeting endometriosis

Intrauterine administration of CDB-2914 (Ulipristal) suppresses the endometrium of rhesus macaques

Efficacy of melatonin in the treatment of endometriosis: a phase II, randomized, double-blind, placebo-controlled trial.

Are aromatase inhibitors effective in endometriosis treatment?

P304

653-664

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/WHE.15.51

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26314760

http://www.w3.org/2001/XMLSchema#string

P921